TRAPPC1
Trafficking protein particle complex subunit 1
Also known as: BET5, MUM2, TPPC1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y5R8
- Gene
- TRAPPC1
- Ensembl
- ENSG00000170043
- Chromosome
- 17
- Canonical length
- 145 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene product plays a role in vesicular transport of proteins to the Golgi apparatus from the endoplasmic reticulum. The encoded protein is a component of the multisubunit transport protein particle (TRAPP) complex. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
145 residues, UniProt reviewed canonical sequence.
>Q9Y5R8|TRAPPC1
1 MTVHNLYLFD RNGVCLHYSE WHRKKQAGIP KEEEYKLMYG MLFSIRSFVS KMSPLDMKDG
61 FLAFQTSRYK LHYYETPTGI KVVMNTDLGV GPIRDVLHHI YSALYVELVV KNPLCPLGQT
121 VQSELFRSRL DSYVRSLPFF SARAGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAPPC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 160 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 160 nTPM
- spleen: 159 nTPM
- thymus: 155 nTPM
- kidney: 153 nTPM
- cerebral cortex: 151 nTPM
- choroid plexus: 148 nTPM
Single-cell type
- platelets: 491 nCPM
- extravillous trophoblasts: 321 nCPM
- megakaryocytes: 303 nCPM
- migrating cytotrophoblasts: 255 nCPM
- cytotrophoblasts: 230 nCPM
- decidual stromal cells: 223 nCPM
Immune cell
- eosinophil: 429 nTPM
- basophil: 318 nTPM
- total PBMC: 306 nTPM
- plasmacytoid DC: 294 nTPM
- T-reg: 290 nTPM
- myeloid DC: 272 nTPM
Brain region
- thalamus: 123 nTPM
- hypothalamus: 106 nTPM
- medulla oblongata: 100 nTPM
- pons: 96 nTPM
- midbrain: 95 nTPM
- white matter: 95 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 1.28
- DepMap mean gene effect
- -1.17
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- COPII vesicle coating
- endoplasmic reticulum to Golgi vesicle-mediated transport
- vesicle coating
- vesicle tethering
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRAPPC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAPPC1 as an antibody target. Whether an autoantibody or antibody against TRAPPC1 could matter depends on whether native TRAPPC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAPPC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRAPPC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...